Clinical Trial Update: A Phase I/II Clinical Study of LBL-024 in Patients With Advanced Malignant Tumors [Phase 1, Phase 2]

View source ↗

Summary

This is an update for a Phase I/II clinical study of LBL-024 in patients with advanced solid tumors, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• LBL-024

Snippet

Sponsor: Nanjing Leads Biolabs Co.,Ltd | Conditions: Advanced Solid Tumor | Phase 1, Phase 2 | Status: RECRUITING